Zora J A, Zimmerman D, Carey T L, O'Connell E J, Yunginger J W
J Allergy Clin Immunol. 1986 Jan;77(1 Pt 1):9-13. doi: 10.1016/0091-6749(86)90315-5.
Short-term, high-dose oral glucocorticoid therapy is often required for control of acute asthma episodes in children. To evaluate possible hypothalamic-pituitary-adrenal (HPA) axis suppression after such therapy, we studied 11 children with just asymptomatic asthma before and at 3 and 10 days after completion of a five-day course of prednisone (up to 2 mg/kg/day in divided doses, maximum dose = 60 mg/day). HPA axis responsiveness was tested by measuring plasma corticosteroid levels before and after insulin-induced hypoglycemia. When these levels were compared to pretreatment levels, there was a statistically significant blunting of the peak corticosteroid responses to hypoglycemia 3 days after completion of the course of prednisone (p less than 0.001). However, corticosteroid responses were normal in all children 10 days after completion of the course of prednisone. We concluded that a single course of short-term, high-dose glucocorticoid therapy in children with asymptomatic asthma produces only transient (less than 10 days) HPA axis suppression.
控制儿童急性哮喘发作通常需要短期、大剂量口服糖皮质激素治疗。为评估此类治疗后可能出现的下丘脑-垂体-肾上腺(HPA)轴抑制情况,我们研究了11例仅患有无症状哮喘的儿童,在其完成一个为期五天的泼尼松疗程(分剂量服用,最高2 mg/kg/天,最大剂量 = 60 mg/天)之前、疗程结束后3天和10天时进行观察。通过测量胰岛素诱发低血糖前后的血浆皮质类固醇水平来检测HPA轴反应性。将这些水平与治疗前水平进行比较时,发现泼尼松疗程结束后3天,对低血糖的皮质类固醇峰值反应出现了具有统计学意义的减弱(p < 0.001)。然而,在泼尼松疗程结束10天后,所有儿童的皮质类固醇反应均正常。我们得出结论,无症状哮喘儿童进行一个疗程的短期、大剂量糖皮质激素治疗只会产生短暂(少于10天)的HPA轴抑制。